Akums Drugs & Pharmaceuticals Ltd. Share Price
423.05 -7.40 (-1.72%)Fundamentals
Market Cap
₹6,659CrEPS
₹22.60Book Value/Share
₹193.65P/E Ratio (TTM)
20.78Industry P/E (TTM)
41.52P/B Ratio
2.16Long Term D/E
0.02ROE
18.00%Dividend Yield (TTM)
0.00%Factor Analysis
Overview
Key stock indicators that show how well a company is doing, making it easier to understand its true value and performance.
Huge Underperformer
Somewhat Undervalued
Excellent Quality
Low Price Fluctuation
Shareholding Pattern
Shareholding pattern shows how a company’s shares (ownership) are distributed among different shareholding entities like promoters, Foreign Institutional Investors (FIIs), Domestic Institutional Investors (DIIs), and retail investors, among others. Changes in the shareholding pattern can indicate the performance outlook of a stock.
FAQs on Akums Drugs & Pharmaceuticals Ltd.
Akums Drugs & Pharmaceuticals Ltd. share price is ₹423.05 as of 14/12/2025, 2:14:51 am. Share/stock prices are volatile and change over the course of a trading day, and may differ basis on exchange (NSE/BSE).
Akums Drugs & Pharmaceuticals Ltd. reported an ROE of 18 for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.
Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for Akums Drugs & Pharmaceuticals Ltd., Promoter held 75.30%, the FII held 2.30%, DII held 9.30%, and the public held 10.50% of the total shares.
You can easily buy shares of Akums Drugs & Pharmaceuticals Ltd. online through Share.Market. If you are an existing user, login to your account, else follow the process to create your own Demat and Trading account in a few easy steps.
The fair value of Akums Drugs & Pharmaceuticals Ltd. is an estimated price at which buyers and sellers would freely trade their shares. The various ways to determine the fair value of an asset include looking at recent market transactions for similar assets, estimating its expected earnings or the cost of replacing it.
Earnings Per Share
Earnings per share (EPS) measures the profit earned by a company for each of its outstanding shares. Generally, the higher a company’s EPS is, the more profitable it is considered to be.
Income Statement
Also called a profit and loss statement, an income statement shows a company’s income, expenses, and how much profit or loss it has made over a specific accounting period. It provides a clear view of how well the business is running.
Balance Sheet
A balance sheet is a financial statement that details a company’s assets, liabilities, and shareholders’ equity at a given time. It helps assess how financially strong and stable the company is.
Cash Flow
Cash flow highlights the cash or cash equivalents moving in and out of a company during a particular period. It provides a clear picture of how well a company manages its cash by tracking its operating, investing and financing activities.
Time Period: Daily
SMA/EMA (Moving Average) Analysis
Bullish Moving Averages0
Bearish Moving Averages16
5 Day
423.9010 Day
423.1020 Day
424.0030 Day
432.8050 Day
442.50100 Day
463.50150 Day
496.20200 Day
495.10Indicators
RSI (14)
44.14MACD (12, 26)
-5.68MACD Signal Line (9)
-7.37MFI (14)
54.49ATR (14)
11.40ADX (14)
12.02ROC (21)
-3.28ROC (125)
-26.08Pivot Analysis
Pivot analysis uses a special price point, called the pivot point, to show the overall market trend during different periods. This pivot point is the average of the previous day’s high, low, and closing prices of a specific asset.
Note: Support and Resistance level for the day, calculated based on price range of the previous trading day.
Volume Analysis
Volume analysis tracks how many shares were traded for a specific period. Total traded volume represents the overall number of shares traded, while combined delivery volume indicates only those shares which are delivered (transferred for ownership). Delivered shares indicate long-term investor interest.
